نتایج جستجو برای: influenza vaccine

تعداد نتایج: 166771  

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014
Suzanne E Ohmit Mark G Thompson Joshua G Petrie Swathi N Thaker Michael L Jackson Edward A Belongia Richard K Zimmerman Manjusha Gaglani Lois Lamerato Sarah M Spencer Lisa Jackson Jennifer K Meece Mary Patricia Nowalk Juhee Song Marcus Zervos Po-Yung Cheng Charles R Rinaldo Lydia Clipper David K Shay Pedro Piedra Arnold S Monto

BACKGROUND Each year, the US Influenza Vaccine Effectiveness Network examines the effectiveness of influenza vaccines in preventing medically attended acute respiratory illnesses caused by influenza. METHODS Patients with acute respiratory illnesses of ≤ 7 days' duration were enrolled at ambulatory care facilities in 5 communities. Specimens were collected and tested for influenza by real-tim...

Journal: :Vaccine 2005
Enrique T Muñoz Michael W Deem

Until now, design of the annual influenza vaccine has relied on phylogenetic or whole-sequence comparisons of the viral coat proteins hemagglutinin and neuraminidase, with vaccine effectiveness assumed to correlate monotonically to the vaccine-influenza sequence difference. We use a theory from statistical mechanics to quantify the non-monotonic immune response that results from antigenic drift...

2013
Tina Falkeborn Andreas Bråve Marie Larsson Britt Åkerlind Ulf Schröder Jorma Hinkula

Annual outbreaks of seasonal influenza are controlled or prevented through vaccination in many countries. The seasonal vaccines used are either inactivated, currently administered parenterally, or live-attenuated given intranasally. In this study three mucosal adjuvants were examined for the influence on the humoral (mucosal and systemic) and cellular influenza A-specific immune responses induc...

Afagh Moattari, Amir Emami Forough Tavakoli Mahmoud Shamsi Shahr Abadi Mohammad Rahim Kadivar Nastaran Khodadad Neda Pirbonyeh

Background: A new pandemic influenza A (H1N1) emerged in April 2009, causing considerable morbidity and mortality. Since mutations in the haemagglutinin (HA) may influence the antigenicity and pathogenicity of the virus, continued epidemiological and molecular characterization for the effective control of pandemic flu and developing of more appropriate vaccine is crucial. Objective: To monitor ...

, ,

Background: Influenza is an acute respiratory viral infectious disease that can cause 650,000 deaths annually. Hospital personnel are highly exposed to it. Attention should be paid to the fact that these people, along with the risk to themselves, spread the infection among other patients and vulnerable groups’ like pediatric patients. The best way to prevent the disease is vaccination, which ha...

Journal: :Journal of virology 2012
Shin Murakami Taisuke Horimoto Mutsumi Ito Ryo Takano Hiroaki Katsura Masayuki Shimojima Yoshihiro Kawaoka

Vaccination is one of the most effective preventive measures to combat influenza. Prospectively, cell culture-based influenza vaccines play an important role for robust vaccine production in both normal settings and urgent situations, such as during the 2009 pandemic. African green monkey Vero cells are recommended by the World Health Organization as a safe substrate for influenza vaccine produ...

Journal: :Pediatrics international : official journal of the Japan Pediatric Society 2004
Taro Maeda Yukihiro Shintani Kanako Nakano Kazuhiro Terashima Yoshiyasu Yamada

BACKGROUND The efficacy of inactivated influenza vaccine in healthy infants and children younger than 24 months has not been confirmed. The aim of the present study was to determine the prophylactic effect of inactivated influenza vaccine against influenza A in healthy children aged 6-24 months. METHODS Healthy infants and young children (6-24 months old) were immunized by subcutaneous inject...

2013
Mari Strengell Niina Ikonen Thedi Ziegler Anu Kantele Veli‐Jukka Anttila Ilkka Julkunen

BACKGROUND Influenza A(H1N1)pdm09 virus has been circulating in human population for three epidemic seasons. During this time, monovalent pandemic and trivalent seasonal influenza vaccination against this virus have been offered to Finnish healthcare professionals. It is, however, unclear how well vaccine-induced antibodies recognize different strains of influenza A(H1N1)pdm09 circulating in th...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015
H Keipp Talbot Hui Nian Yuwei Zhu Qingxia Chen John V Williams Marie R Griffin

BACKGROUND Inactivated influenza vaccines are manufactured using either split-virion or subunit methods. These 2 methods produce similar hemagglutinin antibody responses, but different cellular immune responses. METHODS We compared the effectiveness of split-virion influenza vaccines to that of subunit influenza vaccines using prospectively collected data from adults aged ≥50 years who sought...

2017
Ahmed O. Hassan Omar Amen Ekramy E. Sayedahmed Sai V. Vemula Samuel Amoah Ian York Shivaprakash Gangappa Suryaprakash Sambhara Suresh K. Mittal

The emergence of H5, H7, and H9 avian influenza virus subtypes in humans reveals their pandemic potential. Although human-to-human transmission has been limited, the genetic reassortment of the avian and human/porcine influenza viruses or mutations in some of the genes resulting in virus replication in the upper respiratory tract of humans could generate novel pandemic influenza viruses. Curren...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید